Compare MLGO & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLGO | LTRN |
|---|---|---|
| Founded | 2018 | 2013 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.5M | 49.9M |
| IPO Year | N/A | 2020 |
| Metric | MLGO | LTRN |
|---|---|---|
| Price | $6.14 | $3.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $25.00 |
| AVG Volume (30 Days) | ★ 93.1K | 62.3K |
| Earning Date | 12-16-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 4.04 | N/A |
| Revenue | ★ $61,302,336.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.52 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.98 | $2.55 |
| 52 Week High | $972.00 | $6.12 |
| Indicator | MLGO | LTRN |
|---|---|---|
| Relative Strength Index (RSI) | 38.66 | 44.11 |
| Support Level | $6.44 | $3.19 |
| Resistance Level | $7.05 | $3.68 |
| Average True Range (ATR) | 0.43 | 0.26 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 10.88 | 18.52 |
MicroAlgo Inc is divided into two segments: Central processing algorithm services & Intelligent chips and services. The majority is from the Central Processing Algorithm Services. which refers to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.